DE69626958D1 - Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz - Google Patents

Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz

Info

Publication number
DE69626958D1
DE69626958D1 DE69626958T DE69626958T DE69626958D1 DE 69626958 D1 DE69626958 D1 DE 69626958D1 DE 69626958 T DE69626958 T DE 69626958T DE 69626958 T DE69626958 T DE 69626958T DE 69626958 D1 DE69626958 D1 DE 69626958D1
Authority
DE
Germany
Prior art keywords
amlodipine
congestive heart
felodipine
salts
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626958T
Other languages
English (en)
Other versions
DE69626958T2 (de
Inventor
B Cropp
R Kraska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69626958D1 publication Critical patent/DE69626958D1/de
Publication of DE69626958T2 publication Critical patent/DE69626958T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69626958T 1995-03-16 1996-02-26 Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz Expired - Fee Related DE69626958T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40510895A 1995-03-16 1995-03-16
US405108 1995-03-16
PCT/IB1996/000145 WO1996028185A2 (en) 1995-03-16 1996-02-26 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor

Publications (2)

Publication Number Publication Date
DE69626958D1 true DE69626958D1 (de) 2003-04-30
DE69626958T2 DE69626958T2 (de) 2004-03-18

Family

ID=23602311

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626958T Expired - Fee Related DE69626958T2 (de) 1995-03-16 1996-02-26 Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz

Country Status (12)

Country Link
US (1) US6245787B1 (de)
EP (1) EP0804229B1 (de)
JP (2) JPH11500140A (de)
AT (1) ATE235251T1 (de)
CA (1) CA2215234C (de)
DE (1) DE69626958T2 (de)
DK (1) DK0804229T3 (de)
ES (1) ES2193233T3 (de)
FI (1) FI973691A (de)
MX (1) MX9706957A (de)
PT (1) PT804229E (de)
WO (1) WO1996028185A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
EP0795327A1 (de) * 1996-03-13 1997-09-17 Pfizer Inc. Verwendung von Amlodipin zur Behandlung von Prophylaxe von kongestivem Herzversagen nichtischämischen Ursprungs
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
EP1695716A2 (de) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medizinische Zusammensetzungen enthaltend ein Diuretikum und einen Insulin-Sensibilisator
TW200306799A (en) * 2002-05-17 2003-12-01 Novartis Ag Combination of organic compounds
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
HUP0401170A2 (en) * 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
US20070142473A1 (en) * 2005-12-15 2007-06-21 Lawrence Solomon Dosage forms and methods using ethacrynic acid
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
SG183449A1 (en) 2010-02-24 2012-09-27 Sanofi Aventis Deutschland Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
US20150272930A1 (en) * 2014-04-01 2015-10-01 AILEX Pharmaceuticals PVT. LTD. Fixed Dosage Formulations of Angiotensin Converting Enzyme (ACE) inhibitor and the Diuretic Chlorthalidone
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE3633496A1 (de) 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
NZ242724A (en) 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
EP0795327A1 (de) 1996-03-13 1997-09-17 Pfizer Inc. Verwendung von Amlodipin zur Behandlung von Prophylaxe von kongestivem Herzversagen nichtischämischen Ursprungs

Also Published As

Publication number Publication date
CA2215234C (en) 2001-12-11
EP0804229A2 (de) 1997-11-05
DE69626958T2 (de) 2004-03-18
CA2215234A1 (en) 1996-09-19
FI973691A0 (fi) 1997-09-15
WO1996028185A2 (en) 1996-09-19
JP2003286170A (ja) 2003-10-07
FI973691A (fi) 1997-09-15
DK0804229T3 (da) 2003-04-22
EP0804229B1 (de) 2003-03-26
PT804229E (pt) 2003-06-30
JPH11500140A (ja) 1999-01-06
WO1996028185A3 (en) 1996-10-17
US6245787B1 (en) 2001-06-12
ATE235251T1 (de) 2003-04-15
MX9706957A (es) 1997-11-29
ES2193233T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
DE69626958D1 (de) Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
GR3015087T3 (en) (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol.
ATE230605T1 (de) Wundheilmittel und behandlung von fibrotischen storungen durch tgfbeta-3
ATE228822T1 (de) Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen
SE9401728D0 (sv) New compounds II
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
NO952828D0 (no) Synergiserende blanding med en antagonist-virkning på NK1- og NK2-reseptorer
BR9100221A (pt) Composto;metodo para o tratamento de hipertensao,falha cardiaca congestiva ou glaucoma em um mamifero;e composicao farmaceutica
DE68900485D1 (de) Derivate von phenoxyalkylcarbonsauere und verfahren zu ihrer herstellung.
ATE216237T1 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
DE68907844D1 (de) Mit milchsaeurebakterien gesaeuertes nahrungsmittel und verfahren zu dessen herstellung.
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
ES2041987T3 (es) Metodo y composicion para analgesia oftalmica empleando rodocaina.
DE59005819D1 (de) 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
EA199800033A1 (ru) Антагонисты канала кальция
DE69529070D1 (de) Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv
RU92016264A (ru) Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений
RU96117517A (ru) Способ лечения диабетической ретинопатии
RU98114883A (ru) Способ профилактики несостоятельности культи бронха после пневмонэктомии
ATE58831T1 (de) Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee